Sorrento Therapeutics, Inc.

DB:8STN Stock Report

Market Cap: €154.4m

Sorrento Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 8STN?
Owner TypeNumber of SharesOwnership Percentage
Private Companies20,0000.00368%
Individual Insiders4,697,2610.864%
Institutions46,544,9318.56%
General Public492,450,78090.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 42.6%.

Top Shareholders

Top 25 shareholders own 9.4% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.43%
The Vanguard Group, Inc.
29,535,954€8.4m0%no data
1.64%
Geode Capital Management, LLC
8,905,936€2.5m0%no data
0.84%
Henry Ji
4,577,498€1.3m0%no data
0.69%
Paloma Partners Management Company
3,775,000€1.1m0%0.34%
0.57%
Norges Bank Investment Management
3,125,259€887.8k0%no data
0.037%
Brookfield Corporation
200,000€56.8k0%no data
0.021%
BG Fund Management Luxembourg S.A.
116,291€33.0k0%no data
0.021%
Jaisim Shah
112,633€32.0k0%no data
0.02%
Swisspartners (liechtenstein) AG
110,000€31.2k0%0.03%
0.014%
Lord, Abbett & Co. LLC
77,148€21.9k0%no data
0.013%
Mercer Global Investments Europe Limited
69,903€19.9k0%no data
0.011%
Crescent Grove Advisors, LLC
60,000€17.1k173%no data
0.01%
PHARUS Management SA
54,514€15.5k0%no data
0.0095%
Lattice Capital Management, LLC
51,800€14.7k-18%0.02%
0.0081%
Signal Iduna Asset Management GmbH
44,000€12.5k0%no data
0.0079%
KLP Kapitalforvaltning AS
42,900€12.2k-62.3%no data
0.0072%
S&T Bank, Wealth Management Group
38,853€11.0k0%no data
0.0061%
BMO Asset Management Corp.
33,243€9.4k0%no data
0.006%
GoalVest Advisory LLC
32,915€9.3k-36.3%0.01%
0.0055%
Houlihan Financial Resource Group, Ltd.
30,000€8.5k0%no data
0.005%
Valeo Financial Advisors, LLC
27,473€7.8k0%no data
0.0045%
Keystone Financial Group, LLC
24,700€7.0k0%no data
0.0041%
Granite Bay Wealth Management, LLC
22,520€6.4k17.8%no data
0.0039%
SlateStone Wealth, LLC
21,433€6.1k0%no data
0.0037%
BioVintage inc
20,000€5.7k3,900%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/05/31 00:46
End of Day Share Price 2023/03/03 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sorrento Therapeutics, Inc. is covered by 15 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raghuram SelvarajuAegis Capital Corporation
James MolloyAlliance Global Partners
Difei YangBrean Capital